Clinical trial

Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative…

NCT00498589 · Centre Hospitalier Universitaire de Besancon, Other · Completed

Key facts

NCT number NCT00498589
Title Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis
Official title A Controlled, Randomized, Double-blind, Multicenter Study, Comparing Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis
Acronym METEOR
Lead sponsor Centre Hospitalier Universitaire de Besancon, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Ulcerative Colitis
Intervention type Drug
Interventions methotrexate, placebo
Enrollment 110
Start date Sep 1, 2007
Primary completion Feb 1, 2014
Completion Jun 1, 2014
First posted Jul 10, 2007
Last update posted Feb 5, 2015
Countries Austria, Belgium, France, Israel, Italy, Netherlands

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies